Literature DB >> 8915972

Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.

L A Hebert1, G Agarwal, S E Ladson-Wofford, M Reif, L Hiremath, S G Carlton, N S Nahman, M E Falkenhain, A Agarwal.   

Abstract

Previous studies have shown that African Americans (blacks) tend to have higher nocturnal blood pressure than European Americans (whites). The study presented here was undertaken to determine whether treatment of hypertension influences nocturnal blood pressure differently in blacks than in whites. To answer this question, this study measured nocturnal blood pressure by ambulatory blood pressure monitoring (ABPM) in treated hypertensive blacks and whites whose daytime blood pressures were comparable. Inclusion criteria for this study were: diagnosis of essential hypertension, absence of renal failure, and documentation of antihypertensive therapy, diabetic status, proteinuria status, and body weight. All of the black patients in our programs who underwent ABPM and met the above criteria were included in this study. White patients were included on the basis of having the same inclusion criteria as blacks and showing, by ABPM, daytime mean arterial pressure (MAP) in the same range as that of the blacks selected for this study. The results of nocturnal blood pressure were unknown to the investigators when the patients were selected for this study. In the blacks (N = 62) and whites (N = 72) selected for study, the mean daytime (0600 to 2200 h) MAP was 107 +/- 1 SE mm Hg for both the black and white cohorts. To assess nocturnal blood pressure, the period from 0100 to 0500 h was chosen because it likely encompassed an interval of sleep, which is associated with the nadir of nocturnal blood pressure. This interval was termed 0100 to 0500 h, "middle night." Mean middle night MAP was 97 +/- 12 mm Hg in blacks versus 90 +/- 14 mm Hg in whites (P < 0.006, unpaired t test). The greater middle night MAP in blacks compared with whites was a result of the higher diastolic pressure in blacks (80 +/- 11 mm Hg) versus whites (75 +/- 11 mm Hg) (P = 0.003). Mean middle night systolic blood pressure was numerically higher in blacks than whites (131 +/- 18 mm Hg versus 128 +/- 17 mm Hg), but this difference did not achieve statistical significance. The higher middle night blood pressure in blacks versus whites could not be explained by differences between the groups in daytime MAP, age, gender, body weight, serum creatinine level, proteinuria, diabetic status, or greater use of short-acting antihypertensive agents in blacks versus whites. It was concluded that when treated hypertensive blacks and whites are matched for the same daytime blood pressure, blacks tend to have significantly higher nocturnal blood pressure than whites. The magnitude of this difference suggests that it could contribute importantly to the greater target-organ damage that is seen in hypertensive blacks compared with hypertensive whites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915972     DOI: 10.1681/ASN.V7102130

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  13 in total

Review 1.  Places and health.

Authors:  H V Z Tunstall; M Shaw; D Dorling
Journal:  J Epidemiol Community Health       Date:  2004-01       Impact factor: 3.710

2.  Elderly blacks have a blunted sympathetic neural responsiveness but greater pressor response to orthostasis than elderly whites.

Authors:  Yoshiyuki Okada; M Melyn Galbreath; Sara S Jarvis; Tiffany B Bivens; Wanpen Vongpatanasin; Benjamin D Levine; Qi Fu
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

3.  Does the relationship between natriuretic hormones and diastolic function differ by race?

Authors:  Gaston K Kapuku; Harry C Davis; Patrick Thomas; James Januzzi; Gregory A Harshfield
Journal:  Am J Med Sci       Date:  2012-08       Impact factor: 2.378

4.  Brain natriuretic hormone predicts stress-induced alterations in diastolic function.

Authors:  Pratik Choksy; Harry C Davis; James Januzzi; Julian Thayer; Gregory Harshfield; Vincent J B Robinson; Gaston K Kapuku
Journal:  Am J Med Sci       Date:  2014-11       Impact factor: 2.378

Review 5.  What Are Optimal Blood Pressure Targets for Patients with Hypertension and Chronic Kidney Disease?

Authors:  Gopesh K Modi; Rajiv Agarwal
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

6.  Profile of interdialytic ambulatory blood pressure in a cohort of Chinese patients.

Authors:  W Liu; H Ye; B Tang; Z Song; Z Sun; P Wen; J Yang
Journal:  J Hum Hypertens       Date:  2014-06-12       Impact factor: 3.012

7.  Superiority of Out-of-Office Blood Pressure for Predicting Hypertensive Heart Disease in Non-Hispanic Black Adults.

Authors:  Florian Rader; Stanley S Franklin; James Mirocha; Wanpen Vongpatanasin; Robert W Haley; Ronald G Victor
Journal:  Hypertension       Date:  2019-09-16       Impact factor: 10.190

8.  The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.

Authors:  Marguerite R Irvin; John N Booth; Mario Sims; Adam P Bress; Marwah Abdalla; Daichi Shimbo; David A Calhoun; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-13       Impact factor: 3.738

9.  A comparison of morning blood pressure surge in African Americans and whites.

Authors:  Donald C Haas; Linda M Gerber; Daichi Shimbo; Katherine Warren; Thomas G Pickering; Joseph E Schwartz
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

10.  High prevalence of non-dipping patterns among Black Africans with uncontrolled hypertension: a secondary analysis of the CREOLE trial.

Authors:  Prossie Merab Ingabire; Dike B Ojji; Brian Rayner; Elijah Ogola; Albertino Damasceno; Erika Jones; Anastase Dzudie; Okechukwu S Ogah; Neil Poulter; Mahmoud U Sani; Felix Ayub Barasa; Grace Shedul; John Mukisa; David Mukunya; Bonnie Wandera; Charles Batte; James Kayima; Shahiemah Pandie; Charles Kiiza Mondo
Journal:  BMC Cardiovasc Disord       Date:  2021-05-22       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.